Kınıkoğlu, O. Et Al. 2024. Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) , vol.60, no.6 .

Kınıkoğlu, O., Odabas, H., Altıntaş, Y. E., YILDIZ, A., Çakan, B., Akdağ, G., ... Yıldırım, S.(2024). Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer. Medicina (Kaunas, Lithuania) , vol.60, no.6.

Kınıkoğlu, Oğuzcan Et Al. "Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer," Medicina (Kaunas, Lithuania) , vol.60, no.6, 2024

Kınıkoğlu, Oğuzcan Et Al. "Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer." Medicina (Kaunas, Lithuania) , vol.60, no.6, 2024

Kınıkoğlu, O. Et Al. (2024) . "Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer." Medicina (Kaunas, Lithuania) , vol.60, no.6.

@article{article, author={Oğuzcan Kınıkoğlu Et Al. }, title={Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer}, journal={Medicina (Kaunas, Lithuania)}, year=2024}